Literature DB >> 6511521

Irradiation of nasopharyngeal carcinoma: correlations with treatment factors and stage.

A M Chu, M B Flynn, E Achino, E F Mendoza, R M Scott, B Jose.   

Abstract

Eighty patients with nasopharyngeal carcinoma were treated with radiotherapy in the Radiation Center at the University of Louisville from January 1955 to December 1980. Among the patients were 70 whites, nine blacks and one Chinese; their ages ranged from eight to 82 years. There was a 40% recurrence rate within the nasopharynx, and a 29% recurrence rate within neck nodes. The five year survival and relapse-free survival rates of the entire group were 36 and 33%, respectively. Forty-nine patients died of cancer, four patients died of intercurrent disease and eight patients were lost to follow-up. Nineteen patients are alive and free of disease. Factors considered in this study included tumor and nodal status, the presence of cranial neuropathy, the size and area irradiated, and dose delivered. Primary site relapse was not demonstrated to be dependent on T group or nodal status, but was likely to be related to inadequacy of original treatment volume and dose. A higher survival was noted with our lymphoepithelioma category (p = .056).

Entities:  

Mesh:

Year:  1984        PMID: 6511521     DOI: 10.1016/0360-3016(84)90229-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.

Authors:  Nancy Lee; Jonathan Harris; Adam S Garden; William Straube; Bonnie Glisson; Ping Xia; Walter Bosch; William H Morrison; Jeanne Quivey; Wade Thorstad; Christopher Jones; K Kian Ang
Journal:  J Clin Oncol       Date:  2009-06-29       Impact factor: 44.544

2.  Carcinoma of the nasopharynx--comparison of the UICC and Ho clinical staging systems.

Authors:  S L Roth; G Bertram; H Sack
Journal:  Klin Wochenschr       Date:  1989-01-20

3.  Detection of Epstein-Barr virus in a case of undifferentiated nasopharyngeal carcinoma by in situ hybridization with digoxigenin-labelled PCR-generated probes.

Authors:  P Delvenne; B Kaschten; J M Deneufbourg; L Demanez; A Stevenaert; M Reznik; J Boniver
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

4.  Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial.

Authors:  Richard L Bakst; Nancy Lee; David G Pfister; Michael J Zelefsky; Margie A Hunt; Dennis H Kraus; Suzanne L Wolden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-03       Impact factor: 7.038

5.  A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: Evolving technical choices and survival.

Authors:  S Tonoli; S M Magrini; L Costa; F Paiar; G Simontacchi; V Scotti; N Pasinetti; R Barca; D Barbieri; A De Stefani; E Cellai; M Buglione; G Biti
Journal:  Radiol Med       Date:  2011-11-17       Impact factor: 3.469

6.  Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.

Authors:  M Benasso; G Sanguineti; M D'Amico; R Corvò; I Ricci; G Numico; D Guarneri; V Vitale; E Pallestrini; A Santelli; R Rosso
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

7.  Analysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas.

Authors:  Jian Min Tang; Xiu Mei Ma; Yan Li Hou; Li Yan Dai; Hong Bin Cao; Ming Ye; Yong Rui Bai
Journal:  J Radiat Res       Date:  2014-03-09       Impact factor: 2.724

8.  Site-specific localization of Epstein-Barr virus in pharyngeal carcinomas.

Authors:  S Kojya; T Itokazu; Y Noda; M Ezaki; Y Tomita; M Ohsawa; K Aozasa
Journal:  Jpn J Cancer Res       Date:  1998-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.